According to the latest epidemiological data in 2020, the proportion of diabetic retinopathy (DR) among patients with type 2 diabetes in my country is as high as 30.1%, and women are especially at greater risk.
Diabetic retinopathy (DR) is the direct result of chronic high blood sugar that damages retinal capillaries, leading to leaky and clogged capillaries that can lead to vision loss and even blindness. Diabetes can also contribute to the development of eye diseases such as cataracts, glaucoma, refractive errors and double vision.
Diabetic retinopathy can lead to blindness, but for most patients, blindness is largely preventable. Diabetic retinopathy is usually asymptomatic in its early stages and requires regular eye examinations to judge the condition of the retina and give appropriate treatment in a timely manner.
Diabetic retinopathy is diagnosed and promptly referred to an ophthalmologist for treatment, laser photocoagulation and/or intravitreal injections can stop further vision loss and in some cases even improve vision if treated early .
When DR progresses to advanced disease (vision has been impaired), the treatment options are very limited, and advanced DR requires repeated treatments (such as laser photocoagulation or intravitreal injection of anti-vascular endothelial growth factor drugs), but the effect is often ineffective. Ideal, resulting in a heavy socio-economic burden. Therefore, it is of great significance to find out the risk factors that can help prevent the occurrence of DR and delay the progression of DR.